Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Frankfurt - Delayed Quote • EUR Medicure Inc. (NGQ1.F) Follow Add holdings 0.5100 +0.0100 +(2.00%) At close: April 25 at 9:39:01 PM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for NGQ1.F 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: NGQ1.F View More All News Press Releases SEC Filings Medicure Full Year 2024 Earnings: CA$0.10 loss per share (vs CA$0.088 loss in FY 2023) Medicure to Present Financial Results on April 29, 2025 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2024 Medicure Announces Further Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of West Olympia Pharmacy Medicure Announces Closing of Purchase Agreement for the Acquisition of Gateway Medical Pharmacy Medicure Announces Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of Gateway Medical Pharmacy Medicure Reports Financial Results For Quarter Ended September 30, 2024 Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member Medicure Announces Positive Settlement of Product Development and Supply Contracts Medicure Second Quarter 2024 Earnings: CA$0.12 loss per share (vs CA$0.024 profit in 2Q 2023) Medicure Announces Closing of Asset Purchase Agreement with Canam Bioresearch for Acquisition of Intellectual Property Medicure Reports Financial Results for Quarter Ended June 30, 2024